Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1993-06-11
1994-12-06
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Lymphokine
514 2, 514 8, 514 12, 530351, 930144, 424 852, A61K 3702
Patent
active
053708709
ABSTRACT:
Methods suitable for the protection inhibtion and prevention of the deleterious effects of reactive oxygen species are provided, wherein an effective amount of a protective agent(s) selected from the group of tumor necrosis factor-alpha and -beta, growth hormone, IL-1, and D-factor is administered. Treatment of tissues and organs to be transplanted is described. Perfusion solutions and the preparation of perfused, excised tissue are described.
REFERENCES:
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 4846782 (1989-07-01), Bonnem
patent: 4861587 (1989-08-01), Urbaschek et al.
patent: 4985241 (1991-01-01), Zimmerman et al.
Lowe et al. DNA 8(5):351-59 (1989).
Slordal et al. Eur J. Haematol 43:428-34 (1989).
Berkow, R. et al., "Enhancement of Neutrophil Superoxide Production by Preincubation with Recombinant Human Tumor Necrosis Factor," J. Immunol. 139(1): 3783-3791 (1987).
Braquet, P. et al., "Role of Cytokines and Platelet-Activating Factor in Microvascular Immune Injury," Int. Arch. Allergy Appl. Immunol. 88: 88-100 (1989).
Carswell, E. et al., "An Endotoxin-Induced Serum Factor that Causes Necrosis of Tumors," Proc. Nat. Acad. Sci, USA 73(9): 3666-3670 (1975).
Clark, I and Chaudhri, G., "Interplay of Reactive Oxygen Species and Tumor Necrosis Factor in Tissue Injury," J. Cell. Biochem., UCLA Symposia on Molecular and Cellular Biology, Supplement 12a: 8023 (1988).
Cross, A. et al., "Pretreatment with Recombinant Murine Tumor Necrosis Factor .alpha./Cachectin and Murine Interleukin 1 .alpha. Protects Mice from Lethal Bacterial Infection," J. Exp. Med. 169: 2021-2027 (1989).
Decker, T. and Lohmann-Matthes, M., "A Quick and Simple Method for the Quantitation of Lactate Dehydrogenase Release in Measurements of Cellular Cytotoxicity and Tumor Necrosis Factor (TNF) Activity," J. Immunol. 15: 61-69 (1988).
Galaris, D. et al., "Mechanisms of Reoxygenation Injury in Myocardial Infarction: Implications of a Myoglobin Redox Cycle," Biochem. Biophys. Res. Comm. 160(3): 1162-1168 (1989).
Gordon, T. and Sheppard, D., "Tumor Necrosis Factor Inhibits a Polymorphonuclear Leukocyte-Dependent Airway Edema in Guinea Pigs," J. Appl. Physiol. 64: 1688-1692 (1988).
Hahn, T. et al., "Use of Monoclonal Antibodies to a Human Cytotoxin for Its Isolation and for Examining the Self-Induction of Resistance to this Protein," Proc. Natl. Acad. Sci. USA 82: 3814-3818 (1985).
Hellqvist et al., "Interleukin I Induces New Protein Formation in Isolated Rat Islets of Langerhans," Dialog Information Services, File 155, Medline 66-91, Dialog Accession No. 06998107.
Hjalmarsson, K. et al., "Isolation and Sequence of Complementary DNA Encoding Human Extracellular Superoxide Dismutase," Proc. Natl. Acad. Sci. USA 84: 6340-6344 (1987).
Holtmann and Wallach, "Down Regulation of the Receptors for Tumor Necrosis Factor By Interleukin 1 and 4.beta.-Phorbol-12-Myristate-13-Acetate," J. Immunol. 139(4): 1161-1167 (1987).
Jacob, C. and McDevitt, H., "Tumour Necrosis Factor-.alpha. in Murine Autoimmune `Lupus` Nephritis," Nature 331: 356-358 (1988).
Kalayoglu, M. et al., "Extended Preservation of the Liver for Clinical Transplantation," The Lancet, Mar. 19, 1988 pp. 617-619.
Leurs, R., et al., "Inhibition of Superoxide Anion Radical Production by Ebselen (PZ51) and Its Sulfur Analogue (PZ25) in Guinea Pig Alveolar Macrophages," Biochem. Int'l. 18(2): 295-299 (1989).
Lowe et al., "Genomic Cloning and Heterologous Expression of Human Differentiation-Stimulating Factor," DNA 8(5): 351 (1989).
Maessen, J. et al., "Sensitivity of Ischemically Damaged Kidneys to Inflammatory Reactions," Transplantation Proceedings 21(1): 1261-1262 (1989).
Matsubara, T. and Ziff, M., "Increased Superoxide Anion Release from Human Endothelial Cells in Response to Cytokines," J. Immunol. 137(10): 3295-3298 (1986).
Moreau, J. et al., "Leukaemia Inhibitory Factor is Identical to the Myeloid Growth Factor Human Interleukin for DA Cells," Nature 336: 690 (1988).
Neta, R. et al., "Interdependence of the Radioprotective Effects of Human Recombinant Interleukin 1.alpha., Tumor Necrosis Factor .alpha., Granulocyte Colony-Stimulating Factor, and Murine Recombinant Granulocyte-Macrophage Colony-Stimulating Factor," J. Immunol. 140(1): 108-111 (1988).
Neta, R. and Oppenheim, J., "Cytokines in Therapy of Radiation Injury," Blood 72(3): 1093-1095 (1988).
Neta, R. et al., "Comparison of the In Vivo Effects of rIL-1 and rTNF in Radioprotection, Induction of CSF and of Acute Phase Reactants," Fed. Proc. 46(4): 1200 (Abstract) (1987).
Neta, R. et al., "Interleukin 1 is a Radioprotector," J. Immunol. 136(7): 2483-2485 (1986).
Neta, R., "Role of Cytokines in Radioprotection," Pharmac. Ther. 39: 261-266 (1988).
Neta, R. et al., "Cytokines in Radioprotection. Comparison of the Radioprotective Effects of IL-1 to IL-2, GM-CSF and IFN .gamma.," Lymphokine Research 5,(Suppl. 1): S105-S110 (1986).
Oda, T. et al., "Oxygen Radicals in Influenza-Induced Pathogenesis and Treatment with Pyran Polymer-Conjugated SOD," Science 244: 974-976 (1989).
Omar, B. and McCord, J., "The Cardioprotective Effect of Mn-Superoxide Dismutase is Lost at High Doses in the Postischemic Isolated Rabbit Heart," Free Radical Biology and Medicine 9: 473-478 (1990).
Omar, B. et al., "Cardioprotection by Cu,Zn-Superoxide Dismutase is Lost at High Doses in the Reoxygenated Heart," Free Radical Biology and Medicine 9: 465-471 (1990).
Omar, R. et al., "Antioxidant Enzymes and Survival of Normal and Simian Virus 40-transformed Mouse Embryo Cells after Hyperthermia," Cancer Research 47: 3473-3476 (1987).
Palladino, M. et al., ".gamma.-Irradiation-Induced Mortality: Protective Effect of Protease Inhibitors in Chickens and Mice," Int. J. Radiat. Biol. 41(2): 183-191 (1982).
Saez, J. et al., "Superoxide Dismutase Protects Cultured Neurons Against Death by Starvation," Proc. Natl. Acad. Sci. USA 84: 3056-3059 (1987).
Schutze, S. et al., "Tumor Necrosis Factor-Induced Changes of Gene Expression in U937 Cells," J. Immunol. 140(9): 3000-3005 (1988).
Shalaby, M. et al., "Receptor Binding and Activation of Polymorphonuclear Neutrophils by Tumor Necrosis Factor-Alpha," J. Leukocyte Biol. 41: 196-204 (1987).
Slordal et al., "Radioprotection by Murine and Human Tumor-Necrosis Factor: Dose-Dependent Effects on Hematopoiesis in the Mouse," Eur. J. Haematol. 43: 428-434 (1989).
Sugarman, B. et al., "Recombinant Human Tumor Necrosis Factor-.alpha.: Effects on Proliferation of Normal and Transformed Cells In Vitro," Science 230: 943-945 (1985).
Sullivan, G. et al., "Inhibition of the Inflammatory Action of Interleukin-1 and Tumor Necrosis Factor (alpha) on Neutrophil Function by Pentoxifylline," Infection and Immunity 56(7): 1722-1729 (1988).
Taylor, M. et al., "Pharmacological Protection of Reoxygenation Damage to In Vitro Brain Slice Tissue," Brain Research 347: 268-273 (1985).
Tiegs, G. et al., "Tumor Necrosis Factor is a Terminal Mediator in Galactosamine/Endotoxin-Induced Hepatitis in Mice," Biochem. Pharm. 38(4): 627-631 (1989).
Tsujimoto, M. et al., "Tumor Necrosis Factor Provokes Superoxide Anion Generation From Neutrophils," Biochem. and Biophys. Res. Comm. 137(3): 1094-1100 (1986).
Urbaschek, R. et al., "Tumor Necrosis Factor Induced Stimulation of Granulopoiesis and Radioprotection," Lymphokine Research 6(3): 179-186 (1979).
Wallach, D., "Preparations of Lymphotoxin Induce Resistance to Their Own Cytotoxic Effect," J. Immunol. 132(5): 2464-2469 (1984).
Walton, P. and Cronin, M., "Tumor Necrosis Factor-.alpha. Inhibits Growth Hormone Secretion from Cultured Anterior Pituitary Cells," Endocrinology 125(2): 925-929 (1989).
White, C. et al., "Recombinant Tumor Necrosis Factor/Cachectin and Interleukin 1 Pretreatment Decreases Lung Oxidized Glutathione Accmulation, Lung Injury, and Mortality in Rats Exposed to Hyperoxia," J. Clin. Invest. 79: 1868 (1987).
Wong, G. and Goeddel, D., "Induction of Manganous Superoxide Dismutase by Tumor Necrosis Factor: Possible Protective Mechanism," Science 242: 941-944 (1988).
Zimmerman et al., "Oxidative Damage in Murine Tumor Cells Treated In vitro by Recombinant Human Tumor Necr
Cermak Shelly Guest
Draper Garnette D.
Dregar Ginger
Genentech Inc.
LandOfFree
Method for protection against reactive oxygen species does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for protection against reactive oxygen species, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for protection against reactive oxygen species will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-212905